CN101690792B - Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc - Google Patents
Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc Download PDFInfo
- Publication number
- CN101690792B CN101690792B CN2009101929940A CN200910192994A CN101690792B CN 101690792 B CN101690792 B CN 101690792B CN 2009101929940 A CN2009101929940 A CN 2009101929940A CN 200910192994 A CN200910192994 A CN 200910192994A CN 101690792 B CN101690792 B CN 101690792B
- Authority
- CN
- China
- Prior art keywords
- lumbar
- vertebra
- hyperosteogeny
- cervical vertebra
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc, which comprises the following active compositions in part by weight: 10 to 25 parts of curcuma longa and 3 to 6 parts of sanchi. The Chinese medicinal composition is characterized in that: the two medicaments serve as main raw materials to achieve a treating effect on the hyperosteogeny of lumbar vertebra and cervical vertebra and the protrusion of lumbar vertebral disc through preparation in reasonable proportion by a plurality of ways and a plurality of levels. The Chinese medicinal composition in the invention has few compositions, quick curative effect, high cure rate, no toxic or side effect and low treatment cost, so the Chinese medicinal composition is a perfect medicament for treating the hyperosteogeny of lumbar vertebra and cervical vertebra and the protrusion of lumbar vertebral disc.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relating in particular to by the medium-height grass thing is the Chinese medicine composition that is used for the treatment of lumbar vertebra hyperosteogeny of cervical vertebra, prolapse of lumbar intervertebral disc that primary raw material is made.
Background technology
Bone matrix hyperplasia is called hyperplastic osteoarthritis, osteoarthritis, degenerated arthrosis, senile arthritis, hypertrophiarthritis again, be because soft tissue degeneration, degenerations such as the cartilage in formation joint, intervertebral disc, ligaments, the edge, joint forms bony spur, variations such as synovial membrane plumpness, and osteoclasia appears, cause insecondary hyperosteogeny, cause joint deformity, when being subjected to abnormal load, cause arthralgia, a kind of disease of symptoms such as limitation of activity.Hyperosteogeny is a kind of frequently-occurring disease, commonly encountered diseases, and is particularly commonplace in mid-aged population.
Intervertebral disc prolapse is a frequently-occurring disease, commonly encountered diseases, it mainly because of intervertebral disc strain degeneration, fibrous ring is broken or vertebral pulp is deviate from etc., stimulate or a series of syndromes that compressing spinal nerves, spinal cord etc. cause.Adult's intervertebral disc generation degenerative change, the fibre thickening in the fibrous ring becomes fragile so that eventual failure, makes intervertebral disc lose original elasticity, can not undertake the pressure of bearing originally.In excessive strain, the position cataclysm, under action or the violence bump, fibrous ring gets final product outside bulging with sudden force, thus vertebral pulp also can be outwards outstanding through the crack of disruptive fibrous ring.
Though it is different that the hyperosteogeny at each position, intervertebral disk hernia influence, most patients still are first-selected with the Drug therapy.By the Drug therapy relief of symptoms, remove edema and inflammatory reaction, the nerve of pressurized, the synovial membrane of angioedema might be recovered.Western medicine class drug main will be based on antalgic anti-inflammatory agent, and western medicine eases the pain, and the reaction that controls inflammation improves function of joint.Motherland's traditional medicine as the treatment of rheumatism involving the bone disease, generally is divided into deficiency and excess two big classes to bone matrix hyperplasia, intervertebral disc prolapse on dialectical, void comprises the hepatic and renal YIN deficiency and weak type of qi and blood, comprises rheumatism it is attacked by the cold and evil, phlegm resistance and qi stagnation and blood stasis type in fact.Therefore Chinese traditional treatment bone matrix hyperplasia, intervertebral disc prolapse are many with blood circulation promoting and blood stasis dispelling and medicine for rheumatism, but Chinese medicine preparation components of these treatment hyperosteogenys, intervertebral disk hernia are more, increased the treatment cost.Non-medicine modes such as the employing traction that also has, massage are treated hyperosteogeny, but undesirable for patient with severe symptoms's effect.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of lumbar vertebra hyperosteogeny of cervical vertebra, prolapse of lumbar intervertebral disc, these Chinese medicine composition flavour of a drug are few, and good effect has no side effect.
The Chinese medicine composition of treatment lumbar vertebra hyperosteogeny of cervical vertebra provided by the invention, prolapse of lumbar intervertebral disc is prepared from by the active component of following weight parts proportioning: Rhizoma Curcumae Longae 10～25, Radix Notoginseng 3～6.
Preferred weight part proportioning of preparation Chinese medicine composition of the present invention is: Rhizoma Curcumae Longae 15～20, Radix Notoginseng 4～5.
Optimum weight part proportioning of preparation Chinese medicine composition of the present invention is: Rhizoma Curcumae Longae 20, Radix Notoginseng 5.
The Chinese medicine composition of above-mentioned treatment lumbar vertebra hyperosteogeny of cervical vertebra, prolapse of lumbar intervertebral disc, by common process, can make said multiple dosage form on the pharmaceutics, as pill, powder, capsule, tablet or plaster etc., the patient can oral or external, perhaps oral and external simultaneously.
Rhizoma Curcumae Longae, another name HUANGJIANG, hair Rhizoma Curcumae Longae, tripod perfume (or spice), yellow silk Radix Curcumae.Be irregular oval, cylindrical or spindle, normal crooked, the short dichotomy of the tool that has.The surface buff, coarse, shrinkage texture and obvious link are arranged, and circular branch trace and mark of fibrous root are arranged.Matter is solid, frangibility not, and the pale brown color of section is to golden yellow, and the cutin sample has wax sample gloss, and the endodermis ring grain is obvious, and vascular bundle is point-like and is dispersed in.Gas perfume (or spice) is special, bitter in the mouth, suffering.Function cures mainly: circulation of qi promoting removing blood stasis with potent drugs, inducing menstruation to relieve menalgia.Be used for the twinge of the breast side of body, amenorrhea, lump in the abdomen, rheumatism shoulder arm pain, tumbling and swelling.
Radix Notoginseng is called become civilized Radix Notoginseng, Panax pseudoginseng, Radix Notoginseng, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae), Rhizoma Bergeniae scopulosae.Root taper shape, spindle or irregular bulk.Surface lark or brownish black, tool wax sample gloss has irregular microgroove and the minority hole skin of growing crosswise; The supporting root mark of break of several warty protuberances, top retained root stem foot are arranged at top.Matter is solid, smashes back skin zone and often separates with woody part; Cross section canescence or yellowish-brown, there is brown point in skin zone, bitter in the mouth, little sweet.Function cures mainly: dissipating blood stasis hemostasis, subduing swelling and relieving pain.Be used for various inside and outside hemorrhage, breast ventral spine pain, tumbling and swelling.
The characteristics of Chinese medicine composition of the present invention be with above-mentioned 2 the flavor medicines be primary raw material, prepare by rational proportion, by number of ways, at many levels lumbar vertebra hyperosteogeny of cervical vertebra disease, prolapse of lumbar intervertebral disc are reached therapeutical effect, component is few, curative effect is fast, and the cure rate height has no side effect, the treatment cost is low, is the medicine of a kind of ideal treatment lumbar vertebra hyperosteogeny of cervical vertebra, prolapse of lumbar intervertebral disc.
The specific embodiment
Following examples only are used to set forth the present invention, and protection scope of the present invention is not only to be confined to following examples.The those of ordinary skill of described technical field all can be realized purpose of the present invention according to above content disclosed by the invention and scope that each parameter is got.
Embodiment 1
The treatment lumbar vertebra hyperosteogeny of cervical vertebra that the embodiment of the invention 1 provides, the Chinese medicine composition of prolapse of lumbar intervertebral disc are prepared from by the active component of following weight proportioning: Rhizoma Curcumae Longae 180g, Radix Notoginseng 45g.By the common process on the Chinese materia medica, this Chinese medicine composition is made plaster.
Embodiment 2
The treatment lumbar vertebra hyperosteogeny of cervical vertebra that the embodiment of the invention 2 provides, the Chinese medicine composition of prolapse of lumbar intervertebral disc are prepared from by the active component of following weight proportioning: Rhizoma Curcumae Longae 200g, Radix Notoginseng 50g.By the common process on the Chinese materia medica, this Chinese medicine composition is made plaster.
Embodiment 3
The treatment lumbar vertebra hyperosteogeny of cervical vertebra that the embodiment of the invention 3 provides, the Chinese medicine composition of prolapse of lumbar intervertebral disc are prepared from by the active component of following weight proportioning: Rhizoma Curcumae Longae 150g, Radix Notoginseng 40g.By the common process on the Chinese materia medica, this Chinese medicine composition is made plaster.
Embodiment 4
The treatment lumbar vertebra hyperosteogeny of cervical vertebra that the embodiment of the invention 4 provides, the Chinese medicine composition of prolapse of lumbar intervertebral disc are prepared from by the active component of following weight proportioning: Rhizoma Curcumae Longae 220g, Radix Notoginseng 55g.By the common process on the Chinese materia medica, this Chinese medicine composition is made powder.
Embodiment 5
The treatment lumbar vertebra hyperosteogeny of cervical vertebra that the embodiment of the invention 5 provides, the Chinese medicine composition of prolapse of lumbar intervertebral disc are prepared from by the active component of following weight proportioning: Rhizoma Curcumae Longae 190g, Radix Notoginseng 40g.By the common process on the Chinese materia medica, this Chinese medicine composition is made pill.
Clinical treatment observation
The clinical data statistics:
Through to 667 routine hyperosteogeny patients and prolapse of lumbar intervertebral disc patient clinical treatment statistics, hyperosteogeny of cervical vertebra patient 233 examples wherein, lumbar vertebra matter hypertrophy patient 258 examples, prolapse of lumbar intervertebral disc patient's 176 examples, clinical cure 647 examples, effective 20 examples, total effective rate 100%, cure rate 97%.Show that medicine of the present invention has higher clinical efficacy, it does not find tangible untoward reaction at the treatment viewing duration, shows that safety of medicine of the present invention is effective.
Concrete case introduction:
Case 1: Mrs Chen Zhoulian, people from Lianzhou City, Guangdong Province reports through the People's Hospital, Lianzhou City, Guangdong Province CT examination: L3/4, L4/5 annuler bulge, the horizontal spinal canal stenosis of L4/5 intervertebral disc, L5/S1 intervertebral disk hernia, lumbar vertebra hyperosteogeny.Trial edition invention medicine is after 4 courses of treatment, and transference cure is got well.
Case 2: Chen Lian is with the Ms, people from Lianzhou City, Guangdong Province, through Lianzhou City, Guangdong Province institute of traditional Chinese medicine image center audit report: the slight bulging of waist 3/4 intervertebral disc, waist 4/5 intervertebral disc is outstanding to the right back, and waist 5/ sacrum 1 intervertebral disc is outstanding to the left back, lumbar vertebra hyperosteogeny.Trial edition invention medicine is after 4 courses of treatment, and transference cure is got well.
Case 3: Mr. Hu Xianming, people from Lianzhou City, Guangdong Province is through the report of Lianzhou City, Guangdong Province institute of traditional Chinese medicine CT examination: L4/5 intervertebral disk hernia (central authorities take back type) companion's spinal canal stenosis.Trial edition invention medicine is after 3 courses of treatment, and transference cure is got well.
Case 4: Mr. Chen Rongfu, people from Shenzhen City, Guangdong Province reports through Pingyue County, Shenzhen City, Guangdong Province orthopedics department hospital radiological department CT examination: waist 4/5 annuler bulge, lumbar retrogression.Trial edition invention medicine is after 3 courses of treatment, and transference cure is got well.
Case 5: Mrs Zhang Xirong, people from Lianzhou City, Guangdong Province reports through the outpatient service of radiology department of No.2 Hospital, Tianjin Medical Univ.: the lumbar degenerative osteoarthritis.Trial edition invention medicine is after 3 courses of treatment, and transference cure is got well.
Claims (4)
1. a Chinese medicine composition for the treatment of lumbar vertebra hyperosteogeny of cervical vertebra, prolapse of lumbar intervertebral disc is characterized in that the active component of this Chinese medicine composition and weight portion proportioning thereof are: Rhizoma Curcumae Longae 10～25, Radix Notoginseng 3～6.
2. the Chinese medicine composition of treatment lumbar vertebra hyperosteogeny of cervical vertebra according to claim 1, prolapse of lumbar intervertebral disc, wherein the weight portion proportioning of each active component is: Rhizoma Curcumae Longae 15～20, Radix Notoginseng 4～5.
3. the Chinese medicine composition of treatment lumbar vertebra hyperosteogeny of cervical vertebra according to claim 1, prolapse of lumbar intervertebral disc, wherein the weight portion proportioning of each active component is: Rhizoma Curcumae Longae 20, Radix Notoginseng 5.
4. according to the Chinese medicine composition of claim 1,2 or 3 described treatment lumbar vertebra hyperosteogeny of cervical vertebra, prolapse of lumbar intervertebral disc, the dosage form that it is characterized in that this Chinese medicine composition is pill, powder, capsule, tablet or emplastrum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101929940A CN101690792B (en) | 2009-10-12 | 2009-10-12 | Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101929940A CN101690792B (en) | 2009-10-12 | 2009-10-12 | Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101690792A CN101690792A (en) | 2010-04-07 |
| CN101690792B true CN101690792B (en) | 2011-07-20 |
Family
ID=42079541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009101929940A Expired - Fee Related CN101690792B (en) | 2009-10-12 | 2009-10-12 | Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101690792B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103190616A (en) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | Pseudo-ginseng and grape seed capsules and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100455323C (en) * | 2006-01-13 | 2009-01-28 | 程永军 | Plaster for treating osteosis, protrasion of lumbar intervertebral disc |
-
2009
- 2009-10-12 CN CN2009101929940A patent/CN101690792B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100455323C (en) * | 2006-01-13 | 2009-01-28 | 程永军 | Plaster for treating osteosis, protrasion of lumbar intervertebral disc |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101690792A (en) | 2010-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101181453B (en) | Chinese medicine preparation for curing orthopaedics sickness | |
| CN103006962B (en) | Externally used traditional Chinese medicine liquid for treating osteoproliferation and lumbar disc herniation | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN102370731B (en) | Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof | |
| CN101690792B (en) | Chinese medicinal composition for treating hyperosteogeny of lumbar vertebra and cervical vertebra and protrusion of lumbar vertebral disc | |
| CN100562336C (en) | HUOXUEDAN and preparation method thereof | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN102091169B (en) | Traditional Chinese medicine capsule capable of tonifying liver and kidney, promoting blood circulation by removing blood stasis, dispelling wind, cold and dampness | |
| CN100493552C (en) | Medicine for treating joint disease | |
| CN102038930A (en) | Medicament for treating protrusion of lumbar vertebral disc | |
| CN103784604A (en) | Traditional Chinese medicine composition for treating protrusion of lumbar intervertebral disc, and preparation process and application thereof | |
| CN104547700B (en) | A kind of Chinese medicine composition for the treatment of preceeded menorrhea | |
| CN103040944B (en) | External-use traditional Chinese medicine ointment for treating hyperostosis and lumbar disc herniation | |
| CN104258113B (en) | A kind of Chinese medicine composition for the treatment of cerebral hemorrhage | |
| CN101744901B (en) | Medicinal pillow for treating cervical spondylosis | |
| CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN100434103C (en) | Chinese medicine composition for treating anemogenous-ache disease | |
| CN100353995C (en) | Pharmaceutical composition with functions of dispersing pathogenic wind, activating collaterals ,and clearing away toxin | |
| CN102000198A (en) | Anti-hyperosteogeny Chinese herbal medicine prescription | |
| CN102274458A (en) | Special-effect quick bone setting powder and preparation method thereof | |
| CN102178758A (en) | Medicament for treating peripheral nerve of diabetes | |
| CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
| CN1183918C (en) | Medicine for curing protrution of intervetebral disc and its preparing method | |
| CN1970067A (en) | Chinese medicinal formulation for treating vertebrae hyperosteogeny, protrusion of intervertebral disc and spinal stenosis | |
| CN101623486A (en) | Medicinal composition for treating hyperosteogeny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20161012 |